Tom Mulhern, PhD
Accomplished chemist, manager and project team leader with 29 years experience in big Pharma. Significant contributions in bringing 5 NCEs (new chemical entities) from research to market in human and animal health: Accupril®, Lyrica®, Palladia®, Apoquel®, and Simparica®. Currently Principal in Vector CMC Consulting LLC (founded 2016) offering expertise in process chemistry development and CMC (Chemistry, Manufacturing, and Controls) project leadership and progression.
Formal technical training in synthetic organic and organometallic chemistry (PhD plus 2-year postdoctoral research); direct industrial experience in development, scale-up, and implementation of commercial synthetic routes for APIs (active pharmaceutical ingredients) to ensure Regulatory approval and high quality and reliable commercial supply. Extensive experience in technology transfers to GMP manufacturing facilities in the US, Europe (Ireland, UK, Switzerland, Portugal), and India.
Strong record of accomplishment leading over 20 CMC project teams. Skilled in building high functioning teams with transparency, trust, clear goals and priorities. Excellent track record for delivering process and method robustness, quality, Regulatory approval, speed to market, and sustainable commercial supply.
Demonstrated problem solving skills including determination of root cause, identification of keys to success, and practical implementation of creative solutions. Recognized ability to deliver clear and tailored communication to translate understanding and trust across scientific disciplines, job functions (e.g. science-management), and cultures (especially India-US-Europe) to bring teams together.
COLORADO STATE UNIVERSITY
PhD, Organic Chemistry, 1985
BOISE STATE UNIVERSITY
B.S., Chemistry, 1980
Adjunct Instructor, Department of Chemistry, Western Michigan University (July 2017 – June 2020)